Li et al. found that immunohistochemical staining in colorectal cancer patients showed that eIF4A1 was highly expressed in 86% (44/51) of primary colorectal cancer tissues (LI et al., 2017). This evidence concerns the gene EIF4A1 and colorectal cancer.